Model-Based Analysis of Impact, Costs, and Cost-Effectiveness of Tuberculosis Outbreak Investigations, United States
Emerging Infectious Diseases · 2025-03 · 31 (3)
DOI: 10.3201/eid3103.240633 ↗Kurz gefasst
Fachartikel in der Zeitschrift Emerging Infectious Diseases, 2025-03. Verfasst von Sourya Shrestha und 9 weiteren Autor:innen. Hauptthemen laut MEDLINE: Cost-Benefit Analysis, Disease Outbreaks, Tuberculosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCHHSTP CDC HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Förderung
- NCHHSTP CDC HHS
Zitieren
APA
Shrestha, S., Cilloni, L., Asay, G. R. B., Kammerer, J. S., Raz, K., Shaw, T., Cilnis, M., Wortham, J., Marks, S. M., & Dowdy, D. (2025). Model-Based Analysis of Impact, Costs, and Cost-Effectiveness of Tuberculosis Outbreak Investigations, United States. Emerging Infectious Diseases, 31(3). https://doi.org/10.3201/eid3103.240633
Vancouver
Shrestha S, Cilloni L, Asay GRB, Kammerer JS, Raz K, Shaw T, et al. Model-Based Analysis of Impact, Costs, and Cost-Effectiveness of Tuberculosis Outbreak Investigations, United States. Emerging Infectious Diseases. 2025;31(3). doi:10.3201/eid3103.240633
BibTeX
@article{Shrestha2025,
author = {Shrestha, Sourya and Cilloni, Lucia and Asay, Garrett R Beeler and Kammerer, J Steve and Raz, Kala and Shaw, Tambi and Cilnis, Martin and Wortham, Jonathan and Marks, Suzanne M and Dowdy, David},
title = {Model-Based Analysis of Impact, Costs, and Cost-Effectiveness of Tuberculosis Outbreak Investigations, United States},
journal = {Emerging Infectious Diseases},
year = {2025},
volume = {31},
number = {3},
doi = {10.3201/eid3103.240633}
}
EUVIMED